bombersusan3
About
E2112: Randomized Cycle Three Trial involving Endrocrine system Therapy Plus Entinostat or even Placebo in Hormonal Receptor-Positive Superior Breast cancers. An endeavor with the ECOG-ACRIN Cancer Study Group.
E2112: Randomized Cycle Three Trial involving Endrocrine system Therapy Plus Entinostat or even Placebo in Hormonal Receptor-Positive Superior Breast cancers. An endeavor with the ECOG-ACRIN Cancer Study Group.